| From : | Irinka Tskhomelidze <itskhomelidze@moh.gov.ge> |
| To : | 26ded . <d.danff@gmail.com> |
| Subject : | Re: |
| Cc : | Mariana Mkurnali |
| Received On : | 26.06.2017 07:39 |
Dear Irina!
I already wrote to Farhana that employees of the Center of Expertise and Testing in Healthcare are monitoring the side effects in accordance with the legislation of the Republic of Belarus. Svetlana and I are monitoring the observance of the clinical protocol (correct schemes, duration, need for prolongation of treatment, etc.), so, unfortunately, we can not be useful in this capacity. The start of Sovaldi's treatment is in accordance with the plan: next week, the schemes will be initiated in all patients. According to our data, no side effects have been observed at present.
Yours faithfully, Dzmitry Danilau2017-06-23 12:09 GMT+03:00 Irinka Tskhomelidze <itskhomelidze@moh.gov.ge>:Dear Danilau and Svetlana ,Hope this email finds you well.As per our agreement within HCV elimination project in Belarus you will report AEs to us.Could you please also inform us if there is any progress.Have you already started treatment with Sovaldi and in case if yes how many patients have started treatment.In case if you are not responsible for this please provide us with POC.Thank you in advanceDear Danilau and Svetlana we are looking forward to working with you.--Best regards,Irina Tskhomelidze,Health Care DepartmentMinistry of Labour, Health and Social Affairs of Georgia